Larayne K Oltz, CRMA | |
310 Sunnyview Ln, Kalispell, MT 59901-3129 | |
(406) 751-7695 | |
(406) 755-0971 |
Full Name | Larayne K Oltz |
---|---|
Gender | Female |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 310 Sunnyview Ln, Kalispell, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255384251 | NPI | - | NPPES |
4308259 | Medicaid | MT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | RN7600 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Larayne K Oltz, CRMA 202 Conway Dr, Suite 100, Kalispell, MT 59901-3112 Ph: (406) 751-5662 | Larayne K Oltz, CRMA 310 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 751-7695 |
News Archive
The Public Relations Society of America (PRSA) will bestow the distinguished title of Fellow on Diane Gage Lofgren, senior vice president of Brand Strategy, Communications and PR for Kaiser Permanente, tonight at a ceremony at PRSA's 2009 International Conference in San Diego.
Health officials are investigating whether health care professionals are prescribing antipsychotic drugs too often to children on Medicaid. In the meantime, a Texas compounding pharmacy has become the latest to have its products recalled over meningitis concerns.
Johns Hopkins and other researchers report what is believed to be the first direct evidence in lab animals that the erectile dysfunction drug sildenafil amplifies the effects of a heart-protective protein.
The article published in volume 14 issue 6 of World Journal of Gastroenterology reports on one patient who presented to Dr Cosimo Sperti of University of Padua, Padova, Italy, in 2001 after an exploratory laparotomy performed in another hospital for an unresectable pancreatic cystic mass that had infiltrated the portal vein.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
› Verified 9 days ago
Mr. Timothy John Johnston, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11 5th Ave W, Kalispell, MT 59901 Phone: 406-257-7334 | |
Tafford E Oltz, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-7695 Fax: 406-755-0971 |